Considering that factors upregulated in the acute period after brain ischemia commonly result in a detrimental outcome (such as IL-6, IL-15 [20]), we wondered whether increased cerebral FGF21 expression during the subacute and delay phases could play a positive role. The gene discussed is IL6; the disease is brain ischemia.